Clinical Trials Directory

Trials / Completed

CompletedNCT02282696

Validation Study CARES

Research on Psychosocial Aspects in the Care for Patients With Cancer: Validation Study CARES.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
197 (actual)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
25 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study aims to validate the CARES, a needs assessment instrument which can be used to inventorize cancer patients biopsychosocial distress and care needs. * QUANTITATIVE PART OF THE STUDY: Patients need to fill in a questionnaire package containing questions about social-demographic and medical data, the CARES and convergent measures: Karnofsky Performance Scale (KPS), Hospital Anxiety Depression Scale (HADS), Social Support List (SSL), Maudsley Marital Questionnaire (MMQ), European Organisation for Research and Treatment of Cancer Quality Of Life Core 30 (EORTC-QOL-C30), Distress Thermometer (DT) and a Care Needs Questionnaire. One week after the first questionnaire package participants have to fill in the CARES a second time and answer some questions to evaluate the feasibility of the CARES. * QUALITATIVE PART OF THE STUDY: Participants from the quantitative part of the study and other (ex-) cancer patients who not have to fulfill the criteria of age and cancer stage can participate in a focus group interview. In these focus groups the content validity and preferences on psychosocial screening in care are discussed.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire, focus group participationparticipants of the quantitative part of the study are asked to fill in a questionnaire, participants of the qualitative part are asked to participate in a focus group interview.

Timeline

Start date
2013-01-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-11-04
Last updated
2017-09-01

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02282696. Inclusion in this directory is not an endorsement.